PCV20 Pneumococcal Vaccine in Singapore: Protection Against Serious Pneumococcal Disease

Frontier Healthcare

Pneumococcal disease is a bacterial infection that can lead to serious illness, particularly in older adults, young children, and individuals with chronic medical conditions.

Fortunately, vaccination is one of the most effective ways to reduce the risk of severe infection.

The newer PCV20 pneumococcal vaccine offers broader protection than previous pneumococcal vaccines and is now subsidized in Singapore.

What is pneumococcal disease?

Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae. It spreads through respiratory droplets when an infected person coughs or sneezes. It can cause infections ranging from mild illnesses to life-threatening disease.

The Streptococcus pneumoniae can cause infections such as:

    • Pneumonia (lung infection)
    • Sinus infections
    • Ear infections (otitis media)
    • Bloodstream infections (bacteraemia and sepsis)
    • Meningitis (infection of the lining around the brain and spinal cord)

What are the complications of pneumococcal disease?

Pneumococcal infections can become serious, especially if the bacteria spreads beyond the lungs or upper respiratory tract.

Potential serious complications can include:

    • Severe pneumonia, which can result in breathing problems requiring hospitalisation
    • Bloodstream infections, which can result in sepsis
    • Meningitis (brain infection), which can cause permanent neurological damage 
    • Organ failure and death, particularly in vulnerable individuals

    Who is at risk of serious pneumococcal disease?

      • Older adults aged 65 years and above
      • Smokers
      • People with chronic illnesses such as diabetes, heart disease, lung disease, kidney disease
      • People with weakened immune systems

      How is pneumococcal disease treated?

      Pneumococcal disease is typically treated with antibiotics. However, some strains of Streptococcus pneumoniae have developed resistance to commonly used antibiotics, making treatment more challenging.

      Vaccination remains the most effective strategy for preventing pneumococcal disease, helping to reduce the risk of severe infection and potentially life-threatening complications.

        PCV13, PPSV23 and PCV20: What is the difference?

        There are three main pneumococcal vaccines used in adults:

        Vaccine Protects Against Type of Vaccine Key Features

        PCV13

        (13-valent pneumococcal conjugate vaccine)

        13

        pneumococcal serotypes

        Conjugate vaccine

        Generates a strong and long-lasting immune response.

        Previously the standard conjugate vaccine, followed by PPSV23, for many adults at increased risk of pneumococcal disease.

        PPSV23

        (23-valent pneumococcal polysaccharide vaccine)

        23

        pneumococcal serotypes

        Polysaccharide vaccine

        Provides the broadest serotype coverage but does not generate the same level of immune memory as conjugate vaccines.

        Recommended with PCV13 for certain individuals based on their age or medical conditions.

        PCV20

        (20-valent pneumococcal conjugate vaccine)

        20

        pneumococcal serotypes

        Conjugate vaccine

        Combines the benefits of a conjugate vaccine with broader protection than PCV13.

        For many adults, a single dose provides comprehensive protection without the need for a subsequent vaccine, simplifying the vaccination schedule.

        Which pneumococcal vaccine is right for you?

        The most appropriate pneumococcal vaccine depends on factors such as your age, medical conditions, immune status, and previous pneumococcal vaccinations.

        If you have already received PCV13 or PPSV23, you may still benefit from PCV20 depending on your vaccination history.

        Our family doctors can recommend the most suitable vaccination schedule based on the latest Ministry of Health guidelines.

        The PCV20 vaccine is included under Singapore’s National Adult Immunisation Schedule (NAIS).

        Eligible Singapore Citizens can receive government subsidies at our clinics under the CHAS program.

        Healthier SG-enrolled Singapore Citizens who meet eligibility criteria may receive pneumococcal vaccination at no out-of-pocket cost at their enrolled Healthier SG clinic.

        Protect yourself with pneumococcal vaccination

        If you are aged 65 years or older, have chronic medical conditions, or are at increased risk of pneumococcal disease, speak to one of our family doctors about whether the PCV20 pneumococcal vaccine is suitable for you.

        Vaccination is a simple and effective way to reduce your risk of serious illness and protect your long-term health.

        Author

        Dr Amaris

        Dr Amaris Lim

        MBBS, MMed (Fam Med), GDip (Sports Med)

        Dr Amaris is a Family Physician at Frontier Healthcare with a special interest in Sports Medicine. She also contributes as one of the Core Faculty for the Family Medicine Residency Program with the National University Health System (NUHS). She currently practices at Canberra and Bukit Batok.